How do we find, make and assure quality of conventional medicines?

• In: P2 - Regulatory, manufacturing, supply-chain and quality standards issues on Tuesday, 4 September 2007, 9:00-12:00
• At: Beijing (China) (2007)
• Type: Presentation
• By: TAWAB, Mona (Central Laboratory of German Pharmacists, Eschborn, Germany)
• Abstract:

  Conventional drugs, whether of natural or synthetic origin, result from a complex process of drug development based on the identification of lead compounds and screening for active substances. Unlike complementary medicine they are subject to extensive safety and efficacy testing in the frame of pre-clinical and clinical studies. Furthermore they

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login